ロード中...

Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: a meta-analysis

BACKGROUND AND AIMS: In literature systematic data on treatment with the fixed-dose combination of sofosbuvir and velpatasvir for 12 weeks in anti-HCV/HCV RNA positive subjects with mild fibrosis and naïve to previous Interferon free regimen are scanty. A meta-analysis has been performed to evaluate...

詳細記述

保存先:
書誌詳細
出版年:Acta Biomed
主要な著者: Mariantonietta, Pisaturo, Antonio, Russo, Lorenzo, Onorato, Nicola, Coppola
フォーマット: Artigo
言語:Inglês
出版事項: Mattioli 1885 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6776220/
https://ncbi.nlm.nih.gov/pubmed/31124995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v90i2.8374
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!